JPWO2020223698A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020223698A5 JPWO2020223698A5 JP2021564270A JP2021564270A JPWO2020223698A5 JP WO2020223698 A5 JPWO2020223698 A5 JP WO2020223698A5 JP 2021564270 A JP2021564270 A JP 2021564270A JP 2021564270 A JP2021564270 A JP 2021564270A JP WO2020223698 A5 JPWO2020223698 A5 JP WO2020223698A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- agonist
- biomaterial
- innate immunity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962842068P | 2019-05-02 | 2019-05-02 | |
| US62/842,068 | 2019-05-02 | ||
| PCT/US2020/031169 WO2020223698A1 (en) | 2019-05-02 | 2020-05-01 | Cancer treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022531184A JP2022531184A (ja) | 2022-07-06 |
| JPWO2020223698A5 true JPWO2020223698A5 (zh) | 2023-05-11 |
Family
ID=73029386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564270A Pending JP2022531184A (ja) | 2019-05-02 | 2020-05-01 | がんの処置 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220218822A1 (zh) |
| EP (1) | EP3962524A4 (zh) |
| JP (1) | JP2022531184A (zh) |
| KR (1) | KR20220004077A (zh) |
| CN (1) | CN113766929A (zh) |
| AU (1) | AU2020266676A1 (zh) |
| BR (1) | BR112021021699A8 (zh) |
| CA (1) | CA3132653A1 (zh) |
| IL (1) | IL287652A (zh) |
| WO (1) | WO2020223698A1 (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023534504A (ja) * | 2020-07-17 | 2023-08-09 | サージ セラピューティクス， インコーポレイテッド | ポリマー組み合わせ調製物を含む調製物及び組成物 |
| CN116322702A (zh) * | 2020-08-17 | 2023-06-23 | 萨吉治疗公司 | 用于癌症治疗的髓源性抑制性细胞功能的免疫调节 |
| CN116829182A (zh) * | 2021-01-30 | 2023-09-29 | 萨吉治疗公司 | 癌症治疗 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965379A (en) * | 1991-07-19 | 1999-10-12 | Cytimmune Sciences Inc. | Method for measuring endogenous cytokines |
| AU2003243608A1 (en) * | 2002-06-20 | 2004-01-06 | Royer Biomedical, Inc. | Resorbable delivery systems for the treatment of cancer |
| RU2288730C2 (ru) * | 2005-02-22 | 2006-12-10 | Научно-исследовательский институт Эпидемиологии и микробиологии Сибирского отделения Российской академии наук (НИИ ЭМ СО РАМН) | Способ лечения онкогинекологических больных и гель для его осуществления |
| EP1942950A2 (en) * | 2005-11-01 | 2008-07-16 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Biodegradable composite for internal local radiotherapy |
| GB201004575D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| US20160008399A1 (en) * | 2013-01-14 | 2016-01-14 | Fred Hutchinson Cancer Research Center | Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse |
| AU2016301195B2 (en) * | 2015-08-06 | 2022-09-01 | Dana-Farber Cancer Institute, Inc. | Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses |
| EP3479830A4 (en) * | 2016-04-25 | 2019-08-21 | College of Animal Science & Technology, Qingdao Agriculture University | APPLICATION OF SMALL MOLECULAR HYALURONIC ACID FRAGMENTS |
| KR102650076B1 (ko) * | 2016-08-30 | 2024-03-20 | 다나-파버 캔서 인스티튜트 인크. | 약물 전달 조성물 및 그의 용도 |
| WO2018088933A1 (en) * | 2016-11-14 | 2018-05-17 | Limited Liability Company "Panacela Labs" | Anti-tumor effects of a viral vector encoding a toll-like receptor and a toll-like receptor agonist |
-
2020
- 2020-05-01 BR BR112021021699A patent/BR112021021699A8/pt unknown
- 2020-05-01 CN CN202080032326.6A patent/CN113766929A/zh active Pending
- 2020-05-01 JP JP2021564270A patent/JP2022531184A/ja active Pending
- 2020-05-01 EP EP20798248.9A patent/EP3962524A4/en active Pending
- 2020-05-01 AU AU2020266676A patent/AU2020266676A1/en active Pending
- 2020-05-01 US US17/608,070 patent/US20220218822A1/en active Pending
- 2020-05-01 CA CA3132653A patent/CA3132653A1/en active Pending
- 2020-05-01 WO PCT/US2020/031169 patent/WO2020223698A1/en active Search and Examination
- 2020-05-01 KR KR1020217036221A patent/KR20220004077A/ko unknown
-
2021
- 2021-10-28 IL IL287652A patent/IL287652A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019530658A5 (zh) | ||
| CN103961701A (zh) | 疫苗组合物 | |
| US20210162092A1 (en) | Medical hydrogel | |
| Wu et al. | Biologics‐loaded photothermally dissolvable hyaluronic acid microneedle patch for psoriasis treatment | |
| KR20220004077A (ko) | 암 치료 | |
| CN103961307A (zh) | 经皮给予用wt1肽癌症疫苗组合物 | |
| JP2014169280A (ja) | 経皮または粘膜投与用ワクチン組成物 | |
| JPWO2020223698A5 (zh) | ||
| JP2016034941A (ja) | 液性免疫誘導促進用組成物及びワクチン医薬組成物 | |
| Shen et al. | Tumor immunosuppressive microenvironment modulating hydrogels for second near-infrared photothermal-immunotherapy of cancer | |
| Singh et al. | A review on in vitro—In vivo mucoadhesive strength assessment | |
| Jhawat et al. | Fate and applications of superporous hydrogel systems: a review | |
| US20140220100A1 (en) | Vaccine composition for transdermal administration | |
| JP2016034943A (ja) | 血栓症治療薬を含む液性免疫誘導促進組成物及びワクチン医薬組成物 | |
| JP2016053024A (ja) | ビスホスホネート剤を含む液性免疫用ワクチン医薬組成物 | |
| Singh et al. | Hydrogel as a novel drug delivery system: recent advancements and patents | |
| Salman et al. | An Innovative Mucoadhesive Thermosensitive In situ Gelling Liquid Suppository of Metoclopramide Hydrocloride for Treatment of Nausea and Vomiting Associated with Diseases. | |
| Teng et al. | Nanoparticle loaded thermosensitive nasal in-situ gels for delivery of loratadine: in-vitro & in-vivo evaluation studies | |
| Kandemir et al. | Rheological characterization of Agarose and Poloxamer 407 (P407) based hydrogels | |
| KR20230079036A (ko) | 암 치료를 위한 골수 유래 억제 세포 기능의 면역 조절 | |
| WO2016021601A1 (ja) | 核内受容体リガンドを含む免疫誘導促進用組成物及びワクチン医薬組成物 | |
| Palmer et al. | Injection temperature significantly affects in vitro and in vivo performance of collagen‐platelet scaffolds | |
| Coucke et al. | Influence of heat treatment on spray-dried mixtures of Amioca® starch and Carbopol® 974P used as carriers for nasal drug delivery | |
| US11850388B2 (en) | Method for testing suitability of microneedle material suitable for manufacture employing elongation process, and microneedle manufacturing method comprising same | |
| US20240082236A1 (en) | Cancer therapy |